Search Login Register

Thyrotropin-Releasing Hormone (Protirelin) Summary

Description: A tripeptide that stimulates the release of THYROTROPIN and PROLACTIN. It is synthesized by the neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, TRH (was called TRF) stimulates the release of TSH and PRL from the ANTERIOR PITUITARY GLAND.

Also Known As: Protirelin; Thypinone; Abbott Brand of Protirelin; Abbott-38579; Antepan Show All >>

Networked: 1264 relevant articles (43 outcomes, 110 trials/studies) for this Drug

Key Diseases for which Thyrotropin-Releasing Hormone is Relevant

  1. Graves Disease (Basedow Disease) : 4 outcomes 1 study in 16 results
  2. Neurologic Manifestations (Neurological Manifestations) : 4 outcomes in 5 results
  3. Hyperthyroidism : 3 outcomes 1 study in 38 results
  4. Brain Injuries (Brain Injury) : 3 outcomes 1 study in 8 results
  5. Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) : 2 outcomes 10 studies in 34 results
Show All >>

Drugs Related to Thyrotropin-Releasing Hormone

  1. Thyrotropin (Thyroid-Stimulating Hormone)
  2. Substance P
  3. Prolactin
  4. Dexamethasone (Maxidex)
  5. Triiodothyronine (Liothyronine)
  6. Neuropeptides
  7. tartaric acid (tartrate)
  8. Epinephrine (Adrenaline)
  9. Glucocorticoids
  10. prolinamide
Show All >>

Therapies Related to Thyrotropin-Releasing Hormone

  1. Aftercare (After-Treatment)
  2. Intravenous Injections
  3. Oral Administration
  4. Drug Therapy (Chemotherapy)
  5. Intraperitoneal Injections
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.